NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
22/04/2025
Voltar para busca
Dado oficial do USPTO
NEUROCRINE BIOSCIENCES
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
53
Atualização mais recente
23/04/2025
Tipo de marca
Mista
Classes Nice
5, 44
Data de depósito
16/08/2021
Data de registro
22/04/2025
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
22/04/2025
Última transação
23/04/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
21/12/2024
Primeiro uso no comércio
21/12/2024
Código do desenho
3
Tipo de titular
03
Localização do titular
San Diego, CA
Examinador
CHHINA, KARAN
Unidade examinadora
M50
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of a stylized circular spiral design with "NEUROCRINE" above "BIOSCIENCES" in block lettering to the right.
Titulares e representantes
Titulares
Neurocrine Biosciences, Inc.
Representantes
Allison Strickland Ricketts Fross Zelnick Lehrman & Zissu, P.C.
Classificação técnica
Classes Nice
Classe 5Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for human use for treatment of neuroendocrinological diseasesdisordersconditions; Pharmaceutical preparations for the treatment of hormonal and genetic diseasesdisorders and conditions; pharmaceuticals for human use for the treatment of rare and orphan diseasesdisorders and conditions; pharmaceutical preparations for the treatment of congenital adrenal hyperplasia
Classe 44
providing medical information in the field of hormonal and genetic diseasesdisorders and conditions; on-line information servicesproviding medical information in the field of hormonal and genetic diseasesdisorders and conditions
Publicações
Histórico de despachos e eventos da marca no USPTO.
53 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
22/04/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/04/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/04/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
24/03/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
24/03/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
24/03/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
20/03/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
20/03/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
20/03/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
26/02/2025
DPCC
DIVISIONAL PROCESSING COMPLETE
26/02/2025
IUAF
USE AMENDMENT FILED
06/02/2025
DRRR
DIVISIONAL REQUEST RECEIVED
06/02/2025
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
06/02/2025
EISU
TEAS STATEMENT OF USE RECEIVED
06/02/2025
NOAC
CORRECTED NOA E-MAILED
25/09/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
25/09/2024
EX3G
SOU EXTENSION 3 GRANTED
25/09/2024
DPCC
DIVISIONAL PROCESSING COMPLETE
25/09/2024
EXT3
SOU EXTENSION 3 FILED
02/08/2024
DRRR
DIVISIONAL REQUEST RECEIVED
02/08/2024
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
02/08/2024
EEXT
SOU TEAS EXTENSION RECEIVED
02/08/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
19/01/2024
EX2G
SOU EXTENSION 2 GRANTED
17/01/2024
EXT2
SOU EXTENSION 2 FILED
17/01/2024
EEXT
SOU TEAS EXTENSION RECEIVED
17/01/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
17/08/2023
NOAC
CORRECTED NOA E-MAILED
17/08/2023
EX1G
SOU EXTENSION 1 GRANTED
16/08/2023
DPCC
DIVISIONAL PROCESSING COMPLETE
16/08/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/08/2023
EXT1
SOU EXTENSION 1 FILED
20/07/2023
DRRR
DIVISIONAL REQUEST RECEIVED
20/07/2023
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
20/07/2023
EEXT
SOU TEAS EXTENSION RECEIVED
20/07/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/02/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
13/12/2022
PUBO
PUBLISHED FOR OPPOSITION
13/12/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
23/11/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/11/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/11/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/11/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/11/2022
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
05/05/2022
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
05/05/2022
EPEN
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
05/05/2022
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
05/05/2022
DOCK
ASSIGNED TO EXAMINER
03/05/2022
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
06/10/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/10/2021
NWAP
NEW APPLICATION ENTERED
19/08/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NEUROCRINE BIOSCIENCES ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.